Cantel Medical Corp. (CMN) Reports Q3 EPS of $0.29, Sales Increased 24%
Tweet
Share
E-mailGet Alerts CMN Hot Sheet
Price: $81.14 +0.77%
Financial Fact:
Income before interest, other expense and income taxes: 27.06M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income before interest, other expense and income taxes: 27.06M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cantel Medical Corp. (NYSE: CMN) reported Q3 EPS of $0.29, $0.02 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $82.62 million versus the consensus estimate of $76.17 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Movano (MOVE) Misses Q2 EPS by 195c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
